Tag: benign prostatic hyperplasia treatment devices and equipment market share

  • Strategic Growth Drivers Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Outlook 2025- 2034:Increase In The Number Of Prostate Cancer In Benign Prostatic Hyperplasia Market

    Strategic Growth Drivers Shaping the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Outlook 2025- 2034:Increase In The Number Of Prostate Cancer In Benign Prostatic Hyperplasia Market

    Discover trends, market shifts, and competitive outlooks for the benign prostatic hyperplasia (bph) treatment devices and equipment industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

    How Has The Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Growth Evolved From 2024 To 2025, And What’s Ahead?

    Over the recent years, the market size for benign prostatic hyperplasia (BPH) treatment devices and equipment has seen robust growth. It’s forecasted to increase from $1.29 billion in 2024 to $1.38 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.2%. The historic growth can be linked to factors such as an aging population, increased awareness and diagnostics, healthcare accessibility, and personalized treatment methods.

    The market size for treatment devices and equipment of benign prostatic hyperplasia (BPH) is predicted to experience robust expansion in the forthcoming years. It aims to reach $1.8 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. This anticipated growth during the forecast period can be attributed to the adoption of minimally invasive procedures, growth in emerging markets, regulatory backing, and value-driven healthcare. Key trends during this forecast period entail non-surgical and office-based procedures, the use of laser and radiofrequency technologies, the application of telemedicine and remote consultations, and heightened patient education and participation.

    Download a free sample to assess the report’s scope and structure:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

    Which Factors and External Forces Are Driving Demand in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

    The benign prostatic hyperplasia market is expected to be fueled by the growing number of prostate cancer incidences. Prostate cancer is a type of cancer that originates in the prostate gland, a small organ the size of a walnut situated immediately below the bladder in men. The rise in prostate cancer incidences often leads to more elderly men seeking help for prostate-related conditions. Consequently, this leads to the detection and treatment of benign prostatic hyperplasia. For example, in February 2023, the American Society of Clinical Oncology (ASCO), a professional organization based in the US that shares patient information on its cancer.net website, estimated that there were approximately 288,300 men with prostate cancer in the US in 2023, and there were 268,490 new cases and 34,500 deaths from prostate cancer in 2022. Therefore, the benign prostatic hyperplasia market is being propelled by the escalating number of prostate cancer cases.

    Which Segments in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Offer the Most Growth?

    The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented –

    1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants

    2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types

    3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

    Subsegments:

    1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes

    2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation

    3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers

    4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents

    5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment

    Request customized data on this market:

    https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp

    What Are the Fastest-Growing Geographies in the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

    North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

    Which Cutting-Edge Market Trends Are Expected to Drive the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market’s Growth?

    Key players in the benign prostatic hyperplasia market are concentrating their efforts on creating innovative products including the UroLift 2 System and UroLift ATC advanced tissue control system. These systems have been designed to guarantee dependable solutions within the market. Both UroLift 2 and UroLift ATC systems have been introduced to treat lower urinary tract signs resulting from benign prostatic hyperplasia (BPH), a condition also known as an enlarged prostate. In May 2022, for example, the U.S. medical device company Teleflex Incorporated unveiled both the UroLift 2 and UroLift ATC systems. The UroLift 2 system is an advanced delivery system devised to reach the prostatic urethra and install permanent UroLift implants within the prostate lobes. On the other hand, the UroLift ATC advanced tissue control system offers a minimally invasive treatment option for enlarged prostate symptoms. These systems mark a significant advancement in managing benign prostatic hyperplasia (BPH) by lifting and retaining the enlarged prostate tissue so it no longer obstructs the urethra.

    View the full report here:

    https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

    What Are the Key Elements That Define the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

    Benign prostatic hyperplasia or benign prostatic hypertrophy is a condition of prostate gland enlargement which causes blockade of urethra, the tube that carries urine from the bladder.

    Purchase the full report and get a swift delivery:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Get in touch with us:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

  • How the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

    How the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Will Grow: Key Trends, Market Size, and Opportunities Beyond 2025

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    What Drivers Are Shaping the Growth and Development of theBenign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?

    The benign prostatic hyperplasia (BPH) market is set for significant growth due to the increasing incidence of prostate cancer. Prostate cancer often leads to an increased number of older men seeking medical attention for prostate-related issues, which frequently results in the identification and management of BPH. According to the American Society of Clinical Oncology (ASCO), in 2023, an estimated 288,300 men in the United States were living with prostate cancer, and there were 268,490 new cases and 34,500 deaths from prostate cancer in 2022. This growing prevalence of prostate cancer will likely drive demand for treatments and interventions for BPH, boosting market growth.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

    #What is the Growth Potential of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market, and How Will It Perform by 2034?

    The benign prostatic hyperplasia (BPH) treatment devices and equipment market has grown significantly. It is forecasted to grow from $1.29 billion in 2024 to $1.38 billion in 2025, reflecting a CAGR of 7.2%. Factors behind this growth include the aging global population, improved awareness and diagnoses, healthcare accessibility, and more personalized therapies.

    The benign prostatic hyperplasia (BPH) treatment devices market, expected to grow to $1.8 billion by 2029 with a CAGR of 6.8%, will benefit from minimally invasive procedures and emerging market demand. Non-surgical treatments, telemedicine, and patient engagement will be major trends.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431

    Which Cutting-Edge Market Trends Are Expected to Drive theBenign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market’s Growth?

    In the benign prostatic hyperplasia market, companies are launching novel devices like the UroLift 2 System and UroLift ATC to improve treatment outcomes. These systems are minimally invasive solutions for urinary symptoms associated with BPH. In May 2022, Teleflex Incorporated, a U.S.-based medical device firm, launched these tools to lift and hold prostate tissue without blocking the urethra, representing a significant evolution in BPH treatment.

    What Are the Leading Market Players Impacting theBenign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market’s Growth Trend?

    Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International plc, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic plc, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

    How Are the Key Segments of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market Driving Opportunities and Innovations?

    The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented –

    1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants

    2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types

    3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

    Subsegments:

    1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes

    2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation

    3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers

    4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents

    5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=2431&type=smp

    What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theBenign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market?# Market Expansion?

    North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

    Browse Through More Reports Similar to the Global Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2025, By The Business Research Company:

    Bioabsorbable Stents Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

    Tumor Ablation Therapy Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

    Nephrology And Urology Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/nephrology-and-urology-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Comprehensive Analysis of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Comprehensive Analysis of the Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Market 2025-2034: Growth Rates, Trends, and Future Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the benign prostatic hyperplasia (bph) treatment devices and equipment market size evolved in recent years?

    The market for benign prostatic hyperplasia (BPH) treatment devices and equipment has demonstrated robust growth in recent times. The market value, which stood at $1.29 billion in 2024, is projected to increase to $1.38 billion by 2025, indicating a compound annual growth rate (CAGR) of 7.2%. The significant growth witnessed in the historical period can be attributed to factors such as an aging population, heightened awareness and diagnosis, improved healthcare accessibility, and personalized treatment options.

    What are the predictions for the benign prostatic hyperplasia (bph) treatment devices and equipment market size in the coming years?

    Growth of the benign prostatic hyperplasia (BPH) treatment devices and equipment market is predicted to be robust in the upcoming years, expanding to a size of $1.8 billion by 2029, with a compound annual growth rate (CAGR) of 6.8%. The surge expected during this forecast period is linked to factors such as minimally invasive methods, expansion in emerging markets, regulatory assistance, and value-based healthcare. Key trends projected for this period encompass non-surgical and office-based procedures, use of laser and radiofrequency technologies, telehealth and distant consultations, and increased patient education and involvement.

    Get your benign prostatic hyperplasia (bph) treatment devices and equipment market report here!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

    What key factors are fueling the growth of the benign prostatic hyperplasia (bph) treatment devices and equipment market?

    The anticipated growth of the benign prostatic hyperplasia market can be attributed to the escalating number of prostate cancer cases. Prostate cancer originates in the prostate gland, a small gland shaped like a walnut located under the bladder in males. This resurgence in prostate cancer cases entails an increasing number of older males turning to medical professionals for prostate-related concerns. This scenario brings to the forefront the diagnosis and management of benign prostatic hyperplasia. For instance, the American Society of Clinical Oncology (ASCO), a prominent organization based in the US that delivers patient information on the cancer.net website reported in February 2023 that an estimated 288,300 males in the United States suffered from prostate cancer in the said year, while there were 268,490 fresh cases and 34,500 fatalities as a result of prostate cancer in 2022. Consequently, the rise in prostate cancer cases is fueling the expansion of the benign prostatic hyperplasia market.

    How is the global benign prostatic hyperplasia (bph) treatment devices and equipment market divided into key segments?

    The benign prostatic hyperplasia (BPH) treatment devices and equipment market covered in this report is segmented –

    1) By Product: Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants

    2) By Procedure Type: Transurethral Needle Ablation (TUNA), Transurethral Resection Of Prostate (TURP), Transurethral Incision Of Prostate (TUIP), Transurethral Microwave Thermotherapy (TUMT), Laser Surgery, Other Procedure Types

    3) By End-User: Hospitals, Ambulatory Surgical Centres (ASC), Clinics, Home

    Subsegments:

    1) By Resectoscopes: Bipolar Resectoscopes, Monopolar Resectoscopes, High-Performance Resectoscopes

    2) By Radiofrequency Ablation Device: Single-Needle Radiofrequency Ablation, Multi-Needle Radiofrequency Ablation

    3) By Urology Lasers: Holmium Lasers, Diode Lasers, Green Light Lasers

    4) By Prostatic Stents: Temporary Prostatic Stents, Permanent Prostatic Stents

    5) By Implants: Prostatic Urethral Lift (PUL) Implants, Balloon-Expandable Stents, Permanent Implants for BPH Treatment

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=2431&type=smp

    Who are the key firms paving the way for growth in the benign prostatic hyperplasia (bph) treatment devices and equipment market?

    Major companies operating in the benign prostatic hyperplasia (BPH) treatment devices and equipment market include Karl Storz, Lumenis Ltd., Olympus Corporation, Urologix LLC, Boston scientific Inc., Endo International plc, NeoTract Inc., OmniGuide Inc., Medifocus Inc., ProArc Medical Ltd., Teleflex Incorporated, Medtronic plc, Urotech Devices, Prostalund Operations AB, Baxter International, NxThera Inc., Richard Wolf GmbH, Coloplast A/S, Siemens Healthineers, Quest Pharmatech, Protox Therapeutics, IntelGenx Technologies Corp, Astellas Pharma Inc., Ipsen S.A., Biolitec AG, BVM Medical, Convergent Laser Technologies, Cook Medical, GreenLight Technologies, Merit Medical Systems, Pnn Medical A/S, PROCEPT BioRobotics, Prosenex, ProSolv CardioVascular Inc., Quanta System, Rocamed SAM, RZ Medizintechnik GmbH, SRS Medical Systems, UroShape LLC, Vertebron Inc.

    Which trends are expected to transform the benign prostatic hyperplasia (bph) treatment devices and equipment market?

    Leading businesses in the benign prostatic hyperplasia market are concentrating on the production of novel products, such as the UroLift 2 System and the UroLift ATC advanced tissue control system. These tools were introduced to treat lower urinary tract symptoms arising from benign prostatic hyperplasia (BPH). For example, in May 2022, Teleflex Incorporated, an American medical device corporation, introduced the UroLift 2 System and UroLift ATC. The UroLift 2 System is a designed delivery system that can reach the prostatic urethra to permanently install UroLift implants within the prostate lobes. On the other hand, the UroLift ATC advanced tissue control system is a non-invasive procedure to manage symptoms of an enlarged prostate by lifting and holding the swollen prostate tissue so it doesn’t obstruct the urethra. This is a groundbreaking strategy for the treatment of benign prostatic hyperplasia (BPH).

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2431

    What regions are contributing significantly to the growth of the benign prostatic hyperplasia (bph) treatment devices and equipment market?

    North America was the largest region in the benign prostatic hyperplasia (BPH) treatment devices and equipment market in 2023. Western Europe was the second-largest region in the global benign prostatic hyperplasia (BPH) treatment devices and equipment market. The regions covered in the benign prostatic hyperplasia (BNH) treatment devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Bioabsorbable Stents Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/bioabsorbable-stents-global-market-report

    Tumor Ablation Therapy Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/tumor-ablation-therapy-devices-global-market-report

    Nephrology And Urology Devices Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/nephrology-and-urology-devices-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: